Overview
- Novo Nordisk says the initial 1.5 mg dose is now in pharmacies and select telemedicine outlets, with higher strengths rolling out by the end of the week.
- Cash prices start at $149 per month for the starter dose, rise for higher doses up to $299, and compare with $349 per month for the injectable version for self-pay customers.
- Patients must take the pill on an empty stomach with a small amount of water and wait at least 30 minutes before food, drinks, or other medicines.
- Clinical trials reported about 14% average weight loss at 64 weeks for the pill versus roughly 2% with placebo, with a side-effect profile similar to the injection.
- Novo Nordisk reports U.S. manufacturing in North Carolina and expects to meet demand, while Eli Lilly’s oral orforglipron is expected to seek FDA approval later this year.